154 related articles for article (PubMed ID: 33233912)
1. Inflammatory bowel disease and solid organ transplantation.
Martínez Montiel MDP; Casis Herce B
Rev Esp Enferm Dig; 2021 Jan; 113(1):60-64. PubMed ID: 33233912
[TBL] [Abstract][Full Text] [Related]
2. Clinical management of inflammatory bowel disease in the organ recipient.
Indriolo A; Ravelli P
World J Gastroenterol; 2014 Apr; 20(13):3525-33. PubMed ID: 24707135
[TBL] [Abstract][Full Text] [Related]
3. Incidence of colorectal cancer after liver transplantation for primary sclerosing cholangitis: a systematic review and meta-analysis.
Singh S; Edakkanambeth Varayil J; Loftus EV; Talwalkar JA
Liver Transpl; 2013 Dec; 19(12):1361-9. PubMed ID: 24019127
[TBL] [Abstract][Full Text] [Related]
4. Colorectal cancer in patients with inflammatory bowel disease after liver transplantation for primary sclerosing cholangitis.
Vera A; Gunson BK; Ussatoff V; Nightingale P; Candinas D; Radley S; Mayer A; Buckels JA; McMaster P; Neuberger J; Mirza DF
Transplantation; 2003 Jun; 75(12):1983-8. PubMed ID: 12829898
[TBL] [Abstract][Full Text] [Related]
5. Distinctive inflammatory bowel disease phenotype in primary sclerosing cholangitis.
de Vries AB; Janse M; Blokzijl H; Weersma RK
World J Gastroenterol; 2015 Feb; 21(6):1956-71. PubMed ID: 25684965
[TBL] [Abstract][Full Text] [Related]
6. The impact of inflammatory bowel disease post-liver transplantation for primary sclerosing cholangitis.
Joshi D; Bjarnason I; Belgaumkar A; O'Grady J; Suddle A; Heneghan MA; Aluvihare V; Rela M; Heaton N; Agarwal K
Liver Int; 2013 Jan; 33(1):53-61. PubMed ID: 22103794
[TBL] [Abstract][Full Text] [Related]
7. Activity of Inflammatory Bowel Disease After Liver Transplantation for Primary Sclerosing Cholangitis Predicts Poorer Clinical Outcomes.
Peverelle M; Paleri S; Hughes J; De Cruz P; Gow PJ
Inflamm Bowel Dis; 2020 Nov; 26(12):1901-1908. PubMed ID: 31944235
[TBL] [Abstract][Full Text] [Related]
8. Natural History of Established and De Novo Inflammatory Bowel Disease After Liver Transplantation for Primary Sclerosing Cholangitis.
Mouchli MA; Singh S; Boardman L; Bruining DH; Lightner AL; Rosen CB; Heimbach JK; Hasan B; Poterucha JJ; Watt KD; Kane SV; Raffals LE; Loftus EV
Inflamm Bowel Dis; 2018 Apr; 24(5):1074-1081. PubMed ID: 29522202
[TBL] [Abstract][Full Text] [Related]
9. Inflammatory bowel disease after liver transplantation for primary sclerosing cholangitis.
Singh S; Loftus EV; Talwalkar JA
Am J Gastroenterol; 2013 Sep; 108(9):1417-25. PubMed ID: 23896954
[TBL] [Abstract][Full Text] [Related]
10. Asymptomatic De Novo Inflammatory Bowel Disease Late After Liver Transplantation for Primary Sclerosing Cholangitis: A Case Report.
Åberg F; Abdulle A; Mäkelä A; Nissinen M
Transplant Proc; 2015 Nov; 47(9):2775-7. PubMed ID: 26680092
[TBL] [Abstract][Full Text] [Related]
11. Clinical Characteristics, Associated Malignancies and Management of Primary Sclerosing Cholangitis in Inflammatory Bowel Disease Patients: A Multicentre Retrospective Cohort Study.
Guerra I; Bujanda L; Castro J; Merino O; Tosca J; Camps B; Gutiérrez A; Gordillo Ábalos J; de Castro L; Iborra M; Carbajo AY; Taxonera C; Rodríguez-Lago I; Mesonero F; de Francisco R; Gómez-Gómez GJ; Chaparro M; Tardillo CA; Rivero M; Algaba A; Martín Arranz E; Cañete F; Vicente R; Sicilia B; Antolín B; Prieto V; Márquez L; Benítez JM; Camo P; Piqueras M; Gargallo CJ; Hinojosa E; Huguet JM; Pérez Calle JL; Van Domselaar M; Rodriguez C; Calvet X; Muñoz-Villafranca C; García-Sepulcre MF; Munoz-Garrido P; Fernández-Clotet A; Gómez Irwin L; Hernández S; Guardiola J; Sempere L; González Muñoza C; Hernández V; Beltrán B; Barrio J; Alba C; Moraleja I; López-Sanromán A; Riestra S; Martínez Montiel P; Garre A; Arranz L; García MJ; Martín Arranz MD; Corsino P; Arias L; Fernández-Salazar L; Fernández-Pordomingo A; Andreu M; Iglesias E; Ber Y; Mena R; Arroyo Villarino MT; Mora M; Ruiz L; López-Serrano P; Blazquez I; Villoria A; Fernández M; Bermejo F; Banales JM; Domènech E; Gisbert JP;
J Crohns Colitis; 2019 Dec; 13(12):1492-1500. PubMed ID: 31063540
[TBL] [Abstract][Full Text] [Related]
12. Primary sclerosing cholangitis is protective against nonalcoholic fatty liver disease in inflammatory bowel disease.
Bosch DE; Yeh MM
Hum Pathol; 2017 Nov; 69():55-62. PubMed ID: 28970141
[TBL] [Abstract][Full Text] [Related]
13. Inflammatory bowel disease in liver transplanted patients.
Filipec Kanizaj T; Mijic M
World J Gastroenterol; 2017 May; 23(18):3214-3227. PubMed ID: 28566881
[TBL] [Abstract][Full Text] [Related]
14. Effects of Primary Sclerosing Cholangitis on Risks of Cancer and Death in People With Inflammatory Bowel Disease, Based on Sex, Race, and Age.
Trivedi PJ; Crothers H; Mytton J; Bosch S; Iqbal T; Ferguson J; Hirschfield GM
Gastroenterology; 2020 Sep; 159(3):915-928. PubMed ID: 32445859
[TBL] [Abstract][Full Text] [Related]
15. Epidemiology and outcomes of primary sclerosing cholangitis with and without inflammatory bowel disease in an Australian cohort.
Liu K; Wang R; Kariyawasam V; Wells M; Strasser SI; McCaughan G; Corte C; Leong RW
Liver Int; 2017 Mar; 37(3):442-448. PubMed ID: 27891750
[TBL] [Abstract][Full Text] [Related]
16. Reviewing the Risk of Colorectal Cancer in Inflammatory Bowel Disease After Liver Transplantation for Primary Sclerosing Cholangitis.
Rao BB; Lashner B; Kowdley KV
Inflamm Bowel Dis; 2018 Jan; 24(2):269-276. PubMed ID: 29361103
[TBL] [Abstract][Full Text] [Related]
17. The IBD and PSC Phenotypes of PSC-IBD.
Ricciuto A; Kamath BM; Griffiths AM
Curr Gastroenterol Rep; 2018 Mar; 20(4):16. PubMed ID: 29594739
[TBL] [Abstract][Full Text] [Related]
18. Inflammatory bowel disease following solid organ transplantation.
Hampton DD; Poleski MH; Onken JE
Clin Immunol; 2008 Sep; 128(3):287-93. PubMed ID: 18708022
[TBL] [Abstract][Full Text] [Related]
19. Primary sclerosing cholangitis associated with inflammatory bowel disease: an update.
Rossi RE; Conte D; Massironi S
Eur J Gastroenterol Hepatol; 2016 Feb; 28(2):123-31. PubMed ID: 26636407
[TBL] [Abstract][Full Text] [Related]
20. Inflammatory bowel disease course in liver transplant versus non-liver transplant patients for primary sclerosing cholangitis: LIVIBD, an IG-IBD study.
Ribaldone DG; Imperatore N; Le Grazie M; Furfaro F; Balestrieri P; De Blasio F; Fagoonee S; Mosso E; Boano V; Reggio D; Sarli E; Castiglione F; Milla M; Vecchi M; Saracco GM; Salizzoni M; Romagnoli R; Fiorino G; Astegiano M;
Dig Liver Dis; 2021 Jun; 53(6):712-716. PubMed ID: 32972831
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
